Founded in 2015 under the name Ambulnz, DocGo was born to reimagine healthcare delivery through mobile health and medical transportation. The company rebranded as DocGo in 2021. As of December 2025, DocGo serves more than 1.3 million patients on an annual basis across all 50 U.S. states and the United Kingdom.
DocGo is headquartered at 685 Third Avenue, 9th Floor, New York, NY 10017.
On November 8, 2021, DocGo became a publicly traded company. The company is listed on the Nasdaq Global Market under the ticker DCGO.
In 2025, DocGo celebrated its 10-year anniversary and its 10 millionth patient interaction by ringing the closing bell at Nasdaq.
As of late-2025, DocGo clinical network includes more than 4,000 licensed clinicians and medical professionals, including EMTs, paramedics, nurses, nurse practitioners, and advanced practice providers.
Shares of DocGo are publicly traded on the Nasdaq Global Market under the ticker symbol DCGO.
DocGo does not currently offer a direct stock purchase plan.
DocGo does not currently distribute dividends. The company looks to invest capital into growth initiatives, balance sheet strength, and additional shareholder value creation, including, when appropriate, share repurchases and other strategic uses of capital.
DocGo’s fiscal year ends on December 31.
DocGo released its Q3 2025 financial results on November 10, 2025. Future earnings releases, conference presentations, and investor events are posted on the Events & Presentations section of DocGo’s Investor Relations website.
Lee Bienstock is DocGo’s Chief Executive Officer. He leads all of the company’s strategy, operations, and growth initiatives. Previously, Mr. Bienstock served as the company's President and Chief Operating Officer, responsible for driving strategic expansion and growth across DocGo’s sales, operations, product and technology initiatives. He joined DocGo in 2022 after ten years at Google, where he most recently served as Global Head of Enterprise Partnerships for Devices and Services, following roles across Google Search, YouTube, and Fiber. Mr. Bienstock received his MBA from the Wharton School at the University of Pennsylvania and his BS in Policy Analysis & Management with distinction from Cornell University.
DocGo’s Board of Directors provides governance and strategic oversight for the company. The Board includes leaders with experience in healthcare, technology, finance, and operations. Dr. Stephen K. Klasko was appointed as DocGo’s independent, non-executive board chair, effective October 1, 2024.
A current list of directors and their biographies is available on the Corporate Governance section of DocGo’s Investor Relations website.
Yes. DocGo maintains a Medical Advisory Board composed of physicians and clinical experts and chaired by Ben Bobrow, MD FACEP, Professor of Emergency Medicine at the McGovern Medical School at UTHealth Houston. The Advisory Board works to ensure that DocGo’s services meet the highest standards of care, compliance, and patient safety.
A current list of DocGo’s Medical Advisory Board members and their biographies can be viewed on the Medical Advisory Board section of the company’s website.
DocGo delivers technology-enabled medical transportation and mobile health designed to bring care directly to patients’ homes and communities, helping reduce unnecessary hospital visits. The company offers:
- Mobile health services — Care gap closure, in-home urgent care, preventive care, chronic disease management, and remote monitoring.
- Integrated telehealth and in-person care — mobile health practitioners provide on-site services, supported by advanced practice providers connected via telehealth.
- Medical transportation — non-emergency and specialty medical transportation services in the U.S. and the U.K.
- Event-based medical services — on-site clinical teams deliver coverage for large venues and events.
DocGo’s clients include hospital systems, health insurers, and municipal agencies. Its technology driven service offering enables faster, more cost-effective, and more accessible healthcare delivery.
DocGo operates across the United States and the United Kingdom. In the U.S., the company provides mobile health or medical transportation services in more than 30 states. Through its recent acquisition of SteadyMD, the company also offers virtual care across all 50 US states.
DocGo serves a wide range of healthcare stakeholders, including:
- Hospitals & health systems — providing operational efficiencies and improved patient care with medical transportation and mobile health services.
- States & communities — delivering mobile clinics, care teams, and home visits for underserved populations, as well as 911-dedicated ambulance services.
- Physician practices — supporting primary care and specialists with chronic care management, remote monitoring, house calls, and on-demand services.
- Health plans — engaging members through home visits, telehealth, and gap-closure programs that improve quality metrics and reduce costs.
- Businesses & employers — providing virtual, onsite, and in-home programs that support workforce health, reduce costs, and enhance employee benefits.
Through these partnerships, DocGo works with health systems, insurers, government agencies, and providers to expand access to high-quality, cost-effective care.
Investors can find the latest financial results and company guidance in the Earnings Releases section of DocGo’s Investor Relations website.
DocGo focuses on allocating capital toward where management believes will result in increased shareholder value within its areas of strategic focus. Activities have included investing in organic growth, acquiring other companies, paying down outstanding debt and stock repurchases. Details of capital allocation decisions are disclosed in its quarterly filings.
Yes. DocGo’s proprietary transportation management software is being used as a SaaS solution by leading health systems to manage patient transportation across their vendors and facilities, consolidating data into a single warehouse for unified reporting and insights. The platform also integrates DocGo’s mobile health and transportation services directly with health system’s EHRs, enabling a seamless combination of technology and in-field care to provide faster, more reliable care delivery at scale.
DocGo’s approach to compliance is rooted in doing what is right, following the law, and maintaining a strong culture of integrity. Built on the United States HHS Office of Inspector General’s guidance, our Compliance Program combines policies, training, monitoring, investigations, and preventive safeguards into a strong framework. The company’s Compliance Program also incorporates the Department of Justice’s 2024 Evaluation of Corporate Compliance Programs as a framework for ongoing improvement.
Compliance is a shared responsibility. The Board provides oversight, The Chief Compliance Officer and all leadership set the tone, and all personnel are expected to use good judgment, follow policies, and act ethically. We encourage reporting of concerns without fear of retaliation and offer multiple reporting avenues, including a 24/7 anonymous hotline.
Our approach focuses on protecting patient rights and confidential information, preventing fraud, waste, and abuse, ensuring accurate billing, avoiding and managing conflicts of interest, and maintaining ethical business relationships. We also protect company assets and prioritize privacy, inclusion, and responsible use of technology.
Our compliance efforts have been recognized across the industry, including the Compliance Management Innovation Award from MedTech Breakthrough in 2025, the Best Compliance Practices Award from Health Ethics Trust in 2023, finalist honors for the Risk & Compliance Program of the Year from the Navex Excellence Awards in 2024, and finalist recognition for the Best Compliance & Ethics Program from the Corporate Governance Awards in 2024 and 2025.
All earnings webcasts and presentations are archived in the Events & Presentations section of the IR site. In addition, DocGo shares regular updates on its business model and strategic vision through Proactive Care Now, the company’s digital magazine.
Continental Stock Transfer & Trust
1 State Street, 30th Floor
New York, NY 10004-1561
800-509-5586
cstmail@continentalstock.com
www.continentalstock.com
DocGo always welcomes questions and feedback from its shareholders. To contact the company’s Investor Relations team, please email ir@docgo.com.